A vaccine for Alzheimer’s? New research uses vaccines to break up amyloid beta clumps in the brain. These deposits are made of a protein called beta peptide. The lab isolated an antibody to beta peptide and injected it into early onset Alzheimer’s patients monthly. As the body is exposed to the substance, it builds an immune response against it. This is the same principle that works when you get sick from everyday bugs like strep or the flu.
At the end of the trial, levels of beta peptide dropped in the cerebral spinal fluid, indicating that the vaccine was working. The results were a bit shakier:
Although brain, or cognitive function improved only slightly in four patients, it did not worsen, which would have been expected after six months. Also, mental tasks improved in three patients and stayed the same in the other two.
Don’t get your hopes up yet. Although the vaccine appears to work well in animal models and is quite promising for humans, it does have some problems to iron out. Another, larger trial experienced some unfavorable side effects due to the vaccine.
Unfortunately, although the vaccine appears to clear some of the protein from the brain, a substantial minority of participants in the trial developed a serious complication called encephalitis (inflammation of the brain), with two people dying.